Medical Devices
-
Philips recall of heart monitor software tied to 109 injuries, 2 deaths
Some electrocardiogram events, such as atrial fibrillation or abnormally rapid heartbeats, over two years were not reviewed by healthcare professionals due to a data routing issue.
By Ricky Zipp • Jan. 14, 2025 -
CEO Geoff Martha tells JPM crowd Medtronic is ‘stacking growth drivers’
New technologies for atrial fibrillation, hypertension, diabetes and neurological conditions are poised for fast growth, Martha said Monday at the J.P. Morgan Healthcare Conference.
By Susan Kelly • Jan. 14, 2025 -
Trendline
Medical device industry continues to turn to AI
While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.
By MedTech Dive staff -
CMS starts Medicare coverage analysis for Medtronic, Recor renal denervation devices
J.P. Morgan analysts said the CMS’ review “validates the technology and could potentially move the needle on growth for Medtronic.”
By Nick Paul Taylor • Jan. 14, 2025 -
Medtronic inks distribution deal with Contego with option to buy firm
Medtronic will be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes a carotid stent system and thrombectomy devices.
By Ricky Zipp • Jan. 13, 2025 -
EU medtech regulations reducing options for patients, companies say
Stakeholders branded the MDR and IVDR rules “unreasonably complicated,” “terrible for EU patients and doctors” and “a mess.”
By Nick Paul Taylor • Jan. 13, 2025 -
Eko Health names Justin Spencer as CFO
Spencer’s arrival at Eko comes months after the digital health company appointed his former colleague Brent Lang to its board of directors.
By Nick Paul Taylor • Jan. 10, 2025 -
Fire1 raises $120M to trial heart failure management system
Medtronic and Novo Holdings were among the investors in the funding round.
By Nick Paul Taylor • Jan. 10, 2025 -
Medtronic inks exclusive deal to sell Kuros bone graft device
In the five-year agreement, Medtronic will be the exclusive sales agent for Kuros' product in certain U.S. spine geographies.
By Nick Paul Taylor • Jan. 9, 2025 -
Deep Dive // 2025 outlook
5 medtech trends to watch in 2025
After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.
By Ricky Zipp • Jan. 9, 2025 -
J&J pauses Varipulse PFA cases in US
The temporary halt to investigate reported neurovascular events comes two months after Johnson & Johnson won FDA approval for the pulsed field ablation system.
By Susan Kelly • Jan. 8, 2025 -
Beta Bionics, maker of ‘bionic pancreas,’ files for IPO
Beta Bionics did not disclose the number of shares it will offer or a price range.
By Elise Reuter • Jan. 8, 2025 -
Boston Scientific to buy remaining Bolt Medical stake for up to $664M
The deal for Bolt, developer of an intravascular lithotripsy system to treat coronary and peripheral artery disease, continues Boston Scientific’s brisk run of acquisitions.
By Susan Kelly • Jan. 8, 2025 -
FDA finalizes guidance on device shortage reporting rules
The final version adds information on the devices affected by the guidance and the impact of revised legislation on voluntary notifications.
By Nick Paul Taylor • Jan. 8, 2025 -
FDA aims to stem AI device bias, boost transparency in draft guidance
The document follows the agency’s first digital health advisory meeting and a final guidance on postmarket updates to AI devices.
By Elise Reuter • Jan. 7, 2025 -
Outset Medical to pay down debt after raising nearly $300M
Stifel analyst Rick Wise said the financing, a combination of private stock placement and new loans, should help the dialysis device maker return to revenue growth.
By Susan Kelly • Jan. 7, 2025 -
FDA posts early alert about safety risk of Medline’s fluid delivery sets
The agency issued the alert as part of a pilot to improve the timeliness of communications about actions it believes are likely to be high-risk recalls.
By Nick Paul Taylor • Jan. 6, 2025 -
Sponsored by Altium365
Shift left today: Electronics procurement visibility for reliable device development
Periods of uncertainty test the resolve of even the most well-oiled medical device supply chains.
Jan. 6, 2025 -
Olympus begins CEO search after Kaufmann resignation
Stefan Kaufmann, former CEO of Tokyo-based Olympus, stepped down in October after the company investigated an allegation that the executive purchased illegal drugs.
By Susan Kelly • Jan. 3, 2025 -
FDA closes 2024 with string of early alerts on device safety risks
Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.
By Susan Kelly • Jan. 3, 2025 -
FDA-commissioned review finds no safety concerns linked to tampons
Officials commissioned the independent review in September in response to a study that found tampons may expose users to metals.
By Nick Paul Taylor • Jan. 3, 2025 -
Abbott, Dexcom settle glucose monitor patent lawsuits
The rival companies agreed not to sue each other for the next 10 years.
By Elise Reuter • Jan. 2, 2025 -
Q&A
Few medical devices are designed for children. An FDA-Children’s National collaboration aims to change that.
Kolaleh Eskandanian, chief innovation officer at Children’s National Hospital, said the partnership is meant to address the many challenges with developing devices for children and infants.
By Elise Reuter • Jan. 2, 2025 -
Top 10 medtech deals of 2024
Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.
By Nick Paul Taylor • Jan. 2, 2025 -
CMS proposes Medicare coverage for transcatheter tricuspid replacement
Edwards submitted a request for a national coverage determination in February, after receiving FDA approval for its Evoque device earlier that month.
By Elise Reuter • Updated Dec. 23, 2024 -
Robots, AI and PFA: The top medtech Q&As of 2024
From challenging market leaders to the growing influence of artificial intelligence, medical device executives had a lot to discuss this year. Check out MedTech Dive’s top Q&As of 2024.
By Ricky Zipp • Dec. 20, 2024